Cardinal plots spinoff, CEO switch

Drug distributor Cardinal Health plans to spin off its clinical and medical products divisions into one new public company. Cardinal Chairman and CEO Kerry Clark will stick around through the spin-off and then retire, to be succeeded by Vice Chairman George Barrett. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.

Patients with epithelioid sarcoma previously had no targeted treatment options, but that'll change with Epizyme's approval for Tazverik.